Purespring Therapeutics secures £80 million in Series B funding
9th October 2024 Uncategorised 0
New investment to advance gene therapies for kidney diseases

More: Purespring Therapeutics secures £80 million in Series B funding
Source: News
New investment to advance gene therapies for kidney diseases

More: Purespring Therapeutics secures £80 million in Series B funding
Source: News
© 1994 - 2025 B.M. Pharmaceuticals